Other mycoses, not elsewhere classified/unspecified

AB1_MYSOSIS_NOS

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 B48, B49
  • Hospital discharge: ICD-9 11[7-9]
  • Hospital discharge: ICD-8 117
  • Hospital discharge: excluded ICD-9 117[1-5]
  • Hospital discharge: excluded ICD-8 117[1-3]
  • Cause of death: ICD-10 B48, B49
  • Cause of death: ICD-9 11[7-9]
  • Cause of death: ICD-8 117
  • Cause of death: excluded ICD-9 117[1-5]
  • Cause of death: excluded ICD-8 117[1-3]

2 out of 7 registries used, show all original rules.

104

4. Check minimum number of events

None

104

5. Include endpoints

None

104

6. Filter based on genotype QC (FinnGen only)

104

Control definitions (FinnGen only)

Control exclude
AB1_MYCOSES

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF5

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1022 457 554
Only index persons 724 330 394
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.02
Only index persons 0.01 0.01 0.02
Median age at first event (years)
Whole population 56.38 57.52 55.64
Only index persons 53.71 56.31 51.53

-FinnGen-

Key figures

All Female Male
Number of individuals 104 48 56
Unadjusted period prevalence (%) 0.02 0.02 0.02
Median age at first event (years) 60.41 56.72 63.57

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
88
Matched controls
880
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B49
ICD-10 Finland
Unspecified mycosis
+∞
35.9
32
*
B48.8
ICD-10 Finland
Other specified mycoses
238.8
19.3
19
*
B48.7
ICD-10 Finland
Opportunistic mycoses
+∞
18.4
17
*
J02AC03
ATC
voriconazole; systemic
+∞
12.8
12
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
5.4
11.6
43
132
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
10.7
10.8
21
25
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
13.7
9.5
16
14
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
9.4
9.3
19
25
XW000
NOMESCO Finland
Bone marrow biopsy
11.0
8.2
15
16
TGC00
NOMESCO Finland
Bronchial lavation
20.7
7.8
11
6
A04AA01
ATC
ondansetron; systemic, rectal
9.3
7.5
15
19
11799
ICD-8 Finland
Other systemic mycosis, Unspecified
+∞
7.4
7
*
127
Kela drug reimbursment
Transplant complication
22.2
7.3
10
5
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.3
7.1
22
52
UGC12
NOMESCO Finland
Flexible bronchoscopy
7.3
6.9
16
26
A41.8
ICD-10 Finland
Other specified sepsis
24.8
6.8
9
*
L03AA02
ATC
filgrastim; parenteral
13.7
6.8
11
9
D64.9
ICD-10 Finland
Anaemia, unspecified
5.4
6.7
20
45
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
6.3
6
*
R50.9
ICD-10 Finland
Fever, unspecified
4.3
6.1
23
67

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
27
25
14.24
26.23
4.0
1.9
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
17
17.09
25.35
2.4
1.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
24
21
14.56
24.01
4.1
2.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
15
17.29
23.47
1.7
1.9
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
25
25
12.85
22.98
4.2
1.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
47
107
7.19
21.92
4.6
1.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
35
62
8.00
20.60
6.9
2.6
g/l
8.1
9.7
1.11
35
57
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
19
15
15.27
19.98
2.3
2.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
18
14
15.34
19.05
2.3
1.9
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
20
21
11.55
17.58
4.2
1.9
—
—
—
0
0
(44806118)
15
10
17.36
17.10
3.1
2.1
—
—
—
0
0
(44790047)
15
10
17.36
17.10
3.1
2.1
—
—
—
0
0
(44790049)
15
10
17.36
17.10
3.1
2.1
—
—
—
0
0
(44790048)
15
10
17.36
17.10
3.1
2.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
17
15
13.35
16.64
2.1
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
37
85
6.20
16.60
3.9
1.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
45
124
5.63
16.52
4.8
1.9
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
33
70
6.44
16.03
5.0
3.0
e9/l
79.0
69.9
0.49
28
50
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
20
8
30.46
15.37
2.2
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
35
83
5.85
15.04
3.7
1.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
16
15
12.42
15.02
2.2
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
41
114
5.29
14.68
4.2
1.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
16
16
11.64
14.39
4.0
2.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
10
14.71
13.62
2.5
3.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
15
15
11.52
13.45
4.2
2.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
27
56
6.16
13.24
4.6
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
13
11
13.36
12.88
4.3
2.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
13
11
13.36
12.88
4.3
2.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
13
11
13.36
12.88
4.3
2.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
34
91
5.07
12.53
21.9
6.8
mmol/l
2.2
1.0
0.52
27
70
(3023368) Bacteria identified in Blood by Culture
56
222
4.30
12.37
13.4
4.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
15
17
10.14
12.31
1.7
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
16
20
9.27
12.23
1.6
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
23
49
5.74
10.85
9.6
3.7
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
35
107
4.42
10.78
17.4
5.8
mmol/l
1.1
1.0
0.25
35
102
(3017181) Myelocytes/100 leukocytes in Blood
27
67
5.09
10.75
8.1
3.6
%
1.1
1.0
0.02
15
25
(3002179) Metamyelocytes/100 leukocytes in Blood
24
57
5.17
10.01
8.3
3.7
%
0.8
0.4
0.53
13
15
(42870588) Differential panel, method unspecified - Blood
58
266
3.67
9.81
21.6
5.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
11
11
11.06
9.71
2.2
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
27
74
4.58
9.46
10.6
3.8
mmol/l
2.3
2.1
0.05
20
57
(3012544) pH of Venous blood
27
75
4.51
9.30
11.0
3.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
16
28
6.57
9.11
1.7
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
10
10.96
8.78
6.8
3.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
13
9
16.27
8.46
1.2
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
19
43
5.18
8.29
1.9
1.4
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
68
371
3.41
8.27
20.6
5.5
%
2.2
2.7
1.31
63
349
(3042631) Mycobacterium sp identified in Specimen
10
11
9.95
8.22
8.0
3.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
22
57
4.63
8.20
7.1
3.7
%
0.0
0.5
0.56
12
19
(3002030) Lymphocytes/100 leukocytes in Blood
69
383
3.38
8.09
20.9
5.7
%
24.0
27.8
1.47
64
360
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
13
21
6.93
7.92
2.5
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
11
6
20.25
7.78
3.7
1.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
11
15
8.08
7.71
5.5
6.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
13
22
6.61
7.58
6.8
2.1
u/ml
0.3
0.3
—
6
13
(3042733) HLA Ab [Presence] in Serum
7
0
+∞
7.37
3.3
0.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
10
5
21.89
7.28
3.0
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
5
21.89
7.28
1.4
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
12
20
6.65
7.08
4.4
1.9
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
16
37
4.93
6.76
2.5
1.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
51
263
2.84
6.38
7.4
2.7
u/l
28.8
32.4
0.50
51
253
(3000991) Gas panel - Venous blood
22
69
3.78
6.30
34.7
7.3
—
—
—
0
0
(4035726)
22
70
3.72
6.17
1.8
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
20
60
3.89
6.09
8.1
3.8
%
0.2
0.2
0.01
13
21
(3037692) Legionella sp identified in Specimen by Organism specific culture
9
6
16.23
6.02
2.0
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
10
9
12.13
5.93
1.3
1.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
17
46
4.22
5.92
38.2
6.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
28
5.16
5.92
2.7
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
66
404
2.73
5.71
27.9
7.2
mmol/l
1.2
1.2
1.44
59
342
(3007853) Bacteria identified in Skin by Aerobe culture
26
97
3.24
5.70
4.2
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
13
29
4.98
5.69
2.8
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
19
5.72
5.15
2.2
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
36
173
2.65
4.95
2.0
1.9
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
9
10
9.72
4.89
5.0
2.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
7
12.24
4.87
6.0
2.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
7
12.24
4.87
6.0
2.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
7
12.24
4.87
5.9
2.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
7
12.24
4.87
6.0
2.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
44
236
2.50
4.80
5.8
3.2
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
11
25
4.80
4.68
1.2
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
9
12
8.09
4.45
2.9
3.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
9
9.51
4.36
1.1
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
38
198
2.45
4.34
9.1
2.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
6
12.38
4.34
7.0
2.7
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
7
6
12.38
4.34
2.9
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
6
12.38
4.34
6.7
2.7
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
7
6
12.38
4.34
2.9
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
6
12.38
4.34
6.7
2.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
26
113
2.73
4.29
4.5
2.2
%
31.9
22.5
1.18
21
102
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
30
141
2.58
4.24
6.2
3.3
ng/l
568.2
205.5
0.52
24
106
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
59
383
2.25
3.96
11.7
4.1
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
16
55
3.26
3.94
13.3
4.9
mmol/l
25.3
24.7
0.26
16
55
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
28
133
2.51
3.85
1.8
1.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
7
8
9.27
3.83
1.3
1.0
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
7
8
9.27
3.83
1.9
1.9
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
8
9.27
3.83
1.1
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
11
30
3.98
3.75
6.2
2.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
24
107
2.62
3.74
1.8
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
23
101
2.64
3.69
8.1
3.1
umol/l
5.9
6.3
0.08
23
89
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
9
8.24
3.62
5.6
2.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
9
8.24
3.62
5.6
2.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
9
8.24
3.62
1.0
1.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
9
8.24
3.62
5.6
2.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
9
8.24
3.62
5.6
2.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
35
189
2.28
3.60
5.6
1.9
mg/l
2.5
1.2
0.76
28
145
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
12
36
3.64
3.60
12.3
2.7
%
1.9
1.5
0.40
12
36
(3037756) Immunofixation for Serum or Plasma
9
17
5.68
3.60
3.3
1.6
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
6
10.50
3.54
1.0
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
6
6
10.50
3.54
3.2
1.8
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
6
6
10.50
3.54
3.2
1.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
50
315
2.13
3.50
6.7
3.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
36
199
2.24
3.49
23.3
7.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
35
192
2.24
3.46
5.9
3.7
—
—
—
0
0
(3000492) Spirometry study
19
78
2.76
3.45
1.7
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
10
7.41
3.42
5.6
2.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
10
7.41
3.42
5.6
2.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
8
14
6.09
3.41
16.6
2.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
44
266
2.13
3.41
9.5
2.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
51
329
2.08
3.31
14.7
6.4
inr
1.1
1.2
2.09
11
103
(3007164) IgA [Mass/volume] in Serum or Plasma
32
175
2.20
3.15
2.2
1.4
g/l
2.2
2.3
0.17
24
109
(3021879) Hepatitis B virus core Ab [Presence] in Serum
17
69
2.75
3.15
1.6
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
33
183
2.18
3.14
11.5
5.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
10
29
3.71
3.13
1.7
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
14
51
3.02
3.13
5.4
3.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
16
5.32
3.12
5.0
2.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
8
7.87
3.09
2.0
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
12
6.16
3.07
1.3
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
12
6.16
3.07
1.1
1.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
9
21
4.59
3.07
6.8
4.7
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
5
10.41
3.01
8.2
1.8
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
5
10.41
3.01
4.2
2.8
—
—
—
0
0
(4062490)
5
5
10.41
3.01
1.0
1.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
9
6.99
2.91
1.3
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
9
6.99
2.91
3.7
4.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
48
315
1.97
2.87
2.4
1.9
pmol/l
93.9
97.4
0.14
29
162
(3034770) Mitochondria Ab [Titer] in Serum
8
18
4.72
2.86
1.0
1.2
titre
—
—
—
0
0
(40761535) Cells panel - Urine sediment
15
61
2.70
2.76
3.9
4.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
13
49
2.89
2.74
2.2
2.5
e9/l
3.5
3.7
—
8
42
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
10
6.29
2.73
2.0
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
79
625
2.10
2.66
7.4
3.6
mm/h
19.1
11.5
2.68
74
566
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
15
4.92
2.64
1.7
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
15
4.92
2.64
1.7
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
7
7.43
2.57
1.4
1.3
—
—
—
0
0
(3020891) Body temperature
9
26
3.69
2.55
8.6
4.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
73
569
1.95
2.47
9.1
4.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
11
40
2.96
2.46
7.8
3.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
12
5.23
2.44
2.2
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
12
5.23
2.44
1.2
1.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
38
242
1.90
2.40
12.6
4.4
ph
7.4
7.4
—
8
44
(3015736) pH of Urine
46
313
1.84
2.36
5.1
3.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
14
60
2.54
2.33
5.6
2.9
ml/min/173m2
55.5
65.7
—
8
23
(3019309) Folate [Moles/volume] in Red Blood Cells
27
154
2.02
2.33
2.0
1.6
nmol/l
1243.0
1208.9
0.07
22
113
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
13
4.82
2.30
5.8
4.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
18
4.09
2.29
1.6
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
29
3.30
2.29
6.8
4.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
26
148
2.01
2.25
5.3
3.0
e6/l
0.7
0.9
0.27
17
90
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
9
5.77
2.24
1.0
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
8
25
3.38
2.14
1.9
1.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
69
543
1.80
2.10
9.0
4.2
—
68.7
—
0
10
(3015377) Calcium [Moles/volume] in Serum or Plasma
39
263
1.77
2.00
6.0
3.0
mmol/l
2.3
2.4
1.21
34
231
(1616796) Gas panel - Central venous blood
7
21
3.50
2.00
7.1
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
27
3.12
1.98
2.4
1.9
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
11
4.71
1.96
1.8
1.4
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
5
11
4.71
1.96
1.4
1.6
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
9
35
2.72
1.85
14.8
2.7
%
0.6
0.7
—
9
35
(3035350) Ketones [Presence] in Urine by Test strip
54
408
1.67
1.80
5.4
3.6
estimate
0.0
0.0
—
8
79
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
65
519
1.67
1.72
3.5
2.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
43
309
1.67
1.71
8.2
3.6
e6/l
84.8
69.2
0.08
35
214
(40768804) Tissue Pathology biopsy report
44
321
1.64
1.64
3.2
2.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
23
140
1.83
1.62
5.9
3.3
e6/l
3.1
3.0
0.02
14
82
(3021601) Nitrite [Presence] in Urine by Test strip
53
407
1.62
1.60
8.4
4.9
estimate
0.0
0.0
—
8
77
(3000850) Epithelial cells [#/volume] in Urine
27
175
1.73
1.55
4.9
2.2
e6/l
3.3
4.0
0.32
27
150
(3003694) ABO and Rh group [Type] in Blood
35
244
1.65
1.54
1.6
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
38
271
1.63
1.53
6.8
3.0
e6/l
58.1
284.2
0.45
32
203
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
17
96
1.92
1.50
4.9
3.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
53
412
1.58
1.49
5.5
3.6
estimate
0.0
0.0
—
8
73
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
16
3.23
1.45
1.2
1.8
—
—
—
0
0
(3019225) pH of Specimen
14
77
1.95
1.33
12.6
5.8
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
6
25
2.48
1.26
7.3
1.9
kpa
5.1
5.0
—
6
25
(3027315) Oxygen [Partial pressure] in Blood
6
25
2.48
1.26
7.3
1.9
kpa
7.7
8.6
—
6
25
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
25
2.48
1.26
1.5
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
22
143
1.68
1.24
1.3
1.2
iu/ml
27.6
29.0
—
8
50
(36304419) Bacteria [Presence] in Urine
33
238
1.57
1.24
7.4
2.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
48
377
1.51
1.23
27.2
9.9
e9/l
0.0
0.0
0.00
40
316
(3025941) Bacteria identified in Stool by Culture
10
50
2.11
1.21
1.0
1.3
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
5
20
2.57
1.16
1.2
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
20
2.57
1.16
1.2
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
18
269
0.60
1.14
4.8
4.5
%
24.0
22.2
—
9
133
(4010399)
11
59
1.97
1.12
1.4
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
7
32
2.27
1.10
1.9
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
20
287
0.62
1.07
2.4
2.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
40
315
1.44
0.97
4.9
3.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
32
0.00
0.97
0.0
1.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
27
2.29
0.95
3.5
2.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
42
336
1.42
0.93
5.5
3.4
ng/l
17.8
50.9
1.68
36
222
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
19
129
1.58
0.91
1.3
1.3
u/ml
68.3
8.9
—
6
52
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
8
42
1.98
0.91
2.5
2.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
8
42
1.98
0.91
3.0
4.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
12
73
1.73
0.86
2.0
2.0
nmol/l
10.1
14.3
0.90
12
68
(36660697) Celiac disease serology panel - Serum
11
66
1.75
0.82
1.1
1.1
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
5
23
2.23
0.77
8.4
4.9
g/l
0.0
0.0
—
5
23
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
5
23
2.23
0.77
8.4
4.9
g/l
0.0
0.0
—
5
23
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
14
201
0.65
0.73
2.2
2.9
ug/l
0.9
0.8
—
9
135
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
5
25
2.05
0.73
8.4
4.6
g/l
0.0
0.0
—
5
25
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
26
1.97
0.71
2.2
1.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
17
120
1.50
0.70
1.2
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
10
62
1.68
0.68
9.9
3.8
mmol/l
1.2
1.2
—
10
55
(3049717) Cytology report of Urine Cyto stain
6
35
1.76
0.59
2.0
2.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
12
85
1.47
0.49
1.5
1.9
—
—
—
0
0
(3022621) pH of Urine by Test strip
8
58
1.41
0.43
5.9
2.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
29
245
1.25
0.41
5.8
4.3
mg/mmol
18.4
8.8
0.64
21
161
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
27
229
1.24
0.37
4.6
3.8
estimate
0.0
0.0
—
8
77
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
42
1.45
0.36
1.5
1.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
27
231
1.23
0.34
5.3
3.4
mg/l
119.0
55.9
0.63
20
157
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
12
153
0.76
0.33
1.5
1.5
—
—
—
0
0
(3013512) EKG study
28
248
1.18
0.25
5.0
4.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
6
80
0.73
0.25
2.5
2.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
79
758
1.18
0.24
63.8
13.9
%
37.9
40.6
1.79
57
551
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
12
97
1.27
0.24
14.0
7.0
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
5
37
1.37
0.24
1.2
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
41
1.23
0.22
1.2
2.3
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
1.2
—
0
5
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
4.6
—
2.0
—
0
10
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.3
—
79.2
—
0
14
(3002256) Pathology report gross observation
12
102
1.20
0.16
1.3
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
7
89
0.77
0.15
2.4
2.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
88
865
1.11
0.09
45.5
13.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
7
63
1.12
0.08
1.7
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
79
775
1.08
0.08
38.9
13.1
ml/min/173m2
78.3
82.0
0.62
72
635
(40761536) Microorganisms panel - Urine sediment
8
75
1.07
0.07
5.6
3.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
10
110
0.90
0.05
1.2
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
22
230
0.94
0.04
3.6
3.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
80
790
1.05
0.04
6.3
4.6
mmol/l
6.3
6.0
0.67
75
719
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
75
741
1.04
0.03
5.6
4.4
mu/l
1.7
1.9
0.84
69
659
(3044889) 12 lead EKG panel
58
571
1.04
0.02
7.1
3.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
84
838
1.01
0.00
62.0
13.3
mg/l
28.2
24.2
0.68
79
646
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
82
817
1.02
0.00
5.0
4.9
mmol/l
2.6
2.7
0.58
76
752
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
80
805
0.97
0.00
4.6
4.3
mmol/l
1.3
1.5
1.85
75
738
(3022145) Colonoscopy Study observation
10
96
1.05
0.00
1.5
1.3
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
7
0.00
0.00
0.0
11.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
7
79
0.88
0.00
1.9
1.7
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
12.1
—
0
7
(3051651) Icteric interference index of Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
5
53
0.94
0.00
1.8
1.1
—
33.9
—
0
5
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
7
74
0.94
0.00
1.7
1.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.0
—
57.4
—
0
5
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
5
0.00
0.00
0.0
15.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint AB1_MYSOSIS_NOS and mortality.

Females

Parameter HR [95% CI] p-value
AB1_MYSOSIS_NOS 4.838 [2.52, 9.31] < 0.001
Birth year 0.991 [0.98, 1.0] 0.043

During the follow-up period (1.1.1998 — 31.12.2019), 86 out of 207 females with AB1_MYSOSIS_NOS died.

Males

Parameter HR [95% CI] p-value
AB1_MYSOSIS_NOS 4.742 [2.8, 8.04] < 0.001
Birth year 0.986 [0.98, 1.0] 0.004

During the follow-up period (1.1.1998 — 31.12.2019), 94 out of 240 males with AB1_MYSOSIS_NOS died.

Mortality risk

Mortality risk for people of age

years, who have AB1_MYSOSIS_NOS.

N-year risk Females Males
1 0.397% 1.023%
5 2.369% 4.884%
10 6.124% 12.269%
15 11.84% 22.656%
20 19.31% 36.018%

Relationships between endpoints

Index endpoint: AB1_MYSOSIS_NOS – Other mycoses, not elsewhere classified/unspecified

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data